Stock Price Movement and Market Context
On 4 Mar 2026, Krsnaa Diagnostics Ltd (Stock ID: 1003520) touched an intraday low of Rs.617.4, representing its lowest price point in the past year. This decline occurred despite the stock outperforming its sector by 1.66% on the day. Over the last three consecutive trading sessions, the stock has recorded a cumulative loss of 2.75%, signalling sustained selling pressure. The day’s trading saw a maximum fall of 2.15% from the previous close.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish trend. This contrasts with the broader Hospital & Healthcare Services sector, which itself has declined by 3.16% over the same period. Meanwhile, the Sensex index, after a gap down opening of 1,710.03 points, managed a partial recovery to trade at 78,763.56, down 1.84% for the day.
Financial Performance and Profitability Metrics
Krsnaa Diagnostics Ltd’s recent quarterly results have contributed to the subdued market sentiment. The company reported a profit after tax (PAT) of Rs.15.25 crores for the quarter ended December 2025, reflecting a decline of 27.9% compared to the average of the previous four quarters. This contraction in profitability has weighed on investor confidence.
Interest expenses have increased notably, with the latest six-month figure rising by 21.89% to Rs.15.98 crores. The operating profit to interest ratio for the quarter stands at 5.96 times, the lowest recorded in recent periods, signalling tighter coverage of interest obligations. Despite these pressures, the company maintains a low average debt-to-equity ratio of 0.09 times, which remains a positive aspect of its capital structure.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Institutional Holding and Market Participation
Institutional investors have reduced their stake in Krsnaa Diagnostics Ltd by 0.6% over the previous quarter, now collectively holding 18.03% of the company’s shares. This decline in institutional participation is notable given these investors’ typically rigorous fundamental analysis capabilities. The reduced institutional interest may reflect concerns about the company’s recent financial performance and valuation metrics.
Relative Performance and Valuation
Over the past year, Krsnaa Diagnostics Ltd has underperformed significantly, delivering a negative return of 12.67%. This contrasts with the Sensex’s positive return of 7.91% and the broader BSE500 index’s gain of 11.49% over the same period. Despite the stock’s price decline, the company’s profits have increased by 6.3% year-on-year, resulting in a price-to-earnings-growth (PEG) ratio of 4.4, which suggests a relatively high valuation compared to earnings growth.
The company’s return on capital employed (ROCE) stands at 11%, indicating moderate efficiency in generating returns from its capital base. Furthermore, the enterprise value to capital employed ratio is 2.1, signalling an attractive valuation relative to its peers’ historical averages. The stock’s 52-week high was Rs.891.8, highlighting the extent of the recent price correction.
Krsnaa Diagnostics Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Broader Market Dynamics
The Healthcare Services sector, including hospital and diagnostic services, has experienced a decline of 3.16% recently, reflecting broader pressures within the industry. Krsnaa Diagnostics Ltd’s performance has mirrored this trend but with a sharper decline relative to its sector peers. The Sensex’s trading below its 50-day moving average, despite the 50DMA remaining above the 200DMA, indicates a cautious market environment that has affected stocks across sectors.
Summary of Key Metrics
To summarise, Krsnaa Diagnostics Ltd’s stock has reached a 52-week low of Rs.617.4, following a series of quarterly profit declines and increased interest expenses. Institutional investors have marginally reduced their holdings, and the stock trades below all major moving averages. While the company maintains a low debt-to-equity ratio and a moderate ROCE, its valuation metrics such as PEG ratio and enterprise value to capital employed suggest a cautious outlook from the market.
The stock’s underperformance relative to the Sensex and sector indices over the past year underscores the challenges faced in maintaining investor confidence amid evolving market conditions.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
